Stocks with Implied Volatility Movement

Go back to Stocks with Implied Volatility Movement

While Amgen (AMGN) Primary Endpoint Was Below Expectations, Secondary Endpoint was Encouraging - Goldman Sachs

March 17, 2017 11:05 AM EDT

Goldman Sachs analyst Terence Flynn weighed in on Amgen (NASDAQ: AMGN) after full data from Repatha (PCSK9) Ph3 cardiovascular outcomes trial, FOURIER, was presented.

Flynn commented, "In our view the primary endpoint effect is likely below investor expectations (hence why AMGN... More